Biomarkers for Endometriosis
Recruiting now NCT07713797
Run by Trio Fertility · for 18 to 45 · Women · accepts healthy volunteers
What this study is about
Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy. The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Who can join (things the study team will check)
✅ You may be able to join if…
- Women of reproductive age group (18Y-45Y).
- Women with active endometriosis diagnosed by ultrasound/MRI/laparoscopy.
🚫 You may not be able to join if…
- Women <18Y and >45Y.
- Women with endometriosis during stimulation with gonadotropins.
- Current or prior history of uterine, ovarian, colon, pancreatic, breast or any other type of cancer.
- Any prior history of chronic illness.
- Pregnant women.
✅ You may be able to join if…
- Women of reproductive age group (18Y-45Y).
- Women without endometriosis and any other gynaecological problem.
🚫 You may not be able to join if…
- Women <18Y and >45Y
- Prior history of any disease including cancer or chronic illness.
- Pregnant women.
Where this trial is running
- Trio Fertility, Toronto, Ontario, Canada
Who to contact
Yasaman Sadeghi, M.Sc. · 4165060804 · yasamans@triofertility.com
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07713797.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.